Live Quote · NASDAQEVGNHealthcare· Biotechnology

Evogene Ltd.

$0.43 2.56%($-0.01)
TickerSpark Score
56/100
Mixed
75
Valuation
50
Profitability
55
Growth
68
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EVGN research report →

52-Week Range5% of range
Low
$0.37
Current
$0.43
High
$1.50
Company Overviewwww.evogene.com

About the company

Evogene Ltd. , along with its subsidiaries, operates as a computational biology firm. Its core activity involves the discovery and advancement of products across diverse life-science sectors, such as human health and agriculture, primarily leveraging its proprietary Computational Predictive Biology (CPB) platform.

CEO
Ofer Haviv
IPO
2010
Employees
117
HQ
Rehovot, IL

Price Chart

-68.40% · this period
$1.49$0.94$0.39Jul 02Dec 31Jul 02
Valuation
Market Cap
$3.70M
P/E
-0.31
P/S
2.05
P/B
-1.68
EV/EBITDA
0.23
Div Yield
0.00%
Profitability
Gross Margin
30.93%
Op Margin
-757.22%
Net Margin
-639.39%
ROE
937.72%
ROIC
-100.84%
Growth & Income
Revenue
$3.85M · -30.91%
Net Income
$-8,485,000 · 48.53%
EPS
$-1.08 · 62.63%
Op Income
$-14,034,000
FCF YoY
32.91%
Performance & Tape
52W High
$1.50
52W Low
$0.37
50D MA
$0.65
200D MA
$0.95
Beta
0.78
Avg Volume
1.10M

Get TickerSpark's AI analysis on EVGN

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Feb 3, 26Ravzin Polinaother3,000
Apr 1, 26Ravzin Polinaother1,500
Apr 1, 26Ravzin Polinaother6,000
Apr 1, 26Ravzin Polinaother9,500
Mar 18, 26RECANATI LEONother0
Jun 11, 20RECANATI LEONother250
Jun 11, 21RECANATI LEONother250
Jun 11, 22RECANATI LEONother250
Jun 11, 23RECANATI LEONother250
Jun 11, 24RECANATI LEONother250
Coverage · EVGN

Our EVGN coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on EVGN yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate EVGN report →
Internal Compare

Similar companies

Peers in the same neighborhood.